Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Roivant Sciences Ltd (NASDAQ: ROIV) closed at $11.02 down -4.34% from its previous closing price of $11.52. In other words, the price has decreased by -$4.34 from its previous closing price. On the day, 4.98 million shares were traded. ROIV stock price reached its highest trading level at $11.5 during the session, while it also had its lowest trading level at $11.0.
Ratios:
For a deeper understanding of Roivant Sciences Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.43 and its Current Ratio is at 10.43. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On January 05, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $20.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $14.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $14 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 27 ’24 when Venker Eric sold 176,900 shares for $11.82 per share. The transaction valued at 2,090,958 led to the insider holds 668,680 shares of the business.
Venker Eric sold 177,704 shares of ROIV for $2,050,704 on Dec 30 ’24. The President & COO now owns 740,976 shares after completing the transaction at $11.54 per share. On Dec 27 ’24, another insider, Venker Eric, who serves as the Officer of the company, bought 360,000 shares for $11.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 8022009344 and an Enterprise Value of 3115148288. As of this moment, Roivant’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 63.83 while its Price-to-Book (P/B) ratio in mrq is 1.57. Its current Enterprise Value per Revenue stands at 24.124 whereas that against EBITDA is -2.597.
Stock Price History:
Over the past 52 weeks, ROIV has reached a high of $13.06, while it has fallen to a 52-week low of $9.69. The 50-Day Moving Average of the stock is -7.12%, while the 200-Day Moving Average is calculated to be -3.12%.
Shares Statistics:
For the past three months, ROIV has traded an average of 4.59M shares per day and 4180220 over the past ten days. A total of 733.33M shares are outstanding, with a floating share count of 376.90M. Insiders hold about 48.22% of the company’s shares, while institutions hold 67.68% stake in the company. Shares short for ROIV as of 1734048000 were 44198382 with a Short Ratio of 9.63, compared to 1731628800 on 43348974. Therefore, it implies a Short% of Shares Outstanding of 44198382 and a Short% of Float of 8.09.
